"Defendants caused an opioid crisis that is evidenced by increased rates of addiction, overdose deaths and neonatal abstinence syndrome in Oklahoma," Judge Balkman said in the ruling.
Johnson & Johnson immediately released a statement saying that the company "plans to appeal the opioid judgment in Oklahoma."